Prognostic model based on centrosome-related genes constructed in head and neck squamous cell carcinoma.

Head and neck squamous cell carcinoma (HNSCC) is the most common malignant tumor in the epithelium of the head and neck. The role of the centrosome in malignant tumors is crucial. However, research on the centrosome in HNSCC remains largely unexplored. In this study, bioinformatics tools were utilized to analyze the expression and prognostic significance of centrosome-related genes (CRGs). CRGs exhibited a relatively high mutation frequency in HNSCC. Consensus unsupervised clustering analysis based on the expression profiles of CRGs revealed significant associations with clinical features, prognosis and immune microenvironment in HNSCC. Prognostic features were constructed using univariate and LASSO Cox regression, resulting in a centrosome-related model with eleven features. Patients were classified into high-risk and low-risk groups based on median risk scores. External validation using the GSE41613 dataset from the GEO database confirmed the reliability of the centrosome-related model. The model was associated with the prognosis of HNSCC patients, and centrosome-related features could impact tumor prognosis by influencing the tumor immune microenvironment. Finally, qPCR showed that CRGs were highly expressed in tumor tissues. This study developed a novel centrosome-related prognostic model, applicable for predicting the prognosis and immune landscape of HNSCC patients, offering potential targets for future HNSCC treatment.